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Introduction
Herbal medicine has been recognized as one of useful
treatments for chronic liver diseases. Inchinko-to (TJ135)
consists of Artemisia Capillaris Spike, Gardenia Fruit and
Rhubarb Rhizome. Artemisia Capillaris Spike and Gardenia
Fruit promote bile secretion [1,2]. Rhubarb Rhizome is used
for constipation. Rhubarb Rhizome contains anthraqui-
none derivatives, such as aloe emodin and emodin. TJ135
is used for cholestasis, primary biliary cirrhosis [3] and
hepatitis C [4] in Japan. Although therapeutic benefit of
TJ135 was recently reported on acute liver injury induced
by Fas-induced apoptosis of hepatocytes [5], its effect on
liver fibrosis has never been studied so far. In the present
study, we investigated the effect of TJ135 and its compo-
nent on the activation of rat hepatic stellate cells in pri-
mary culture [6]. In vivo effect of TJ135 on an experimental
liver fibrosis caused by thioacetamide (TAA) administra-
tion was also studied.
Methods
Isolated rat HSCs were cultured on plastic dishes in
DMEM in the presence or absence of 10% FBS for 2 days
and were successively exposed to TJ135 or its component
for the following 2 days. DNA synthesis was evaluated by
BrdU uptake. Effect of TJ135 and its component on the
expression of smooth muscle alpha-actin and PDGFR beta
was evaluated by western blot. Effect of these agents on
the phosphorylations of MAPK, Akt, c-raf-1 and PDGFR
beta was estimated using phospho-specific antibodies.
In vivo experimental liver fibrosis was induced in rats by
injecting TAA. TJ135 was administered every day orally.
After 3 weeks, rats were sacrificed. Formalin-fixed liver sec-
tions were stained with sirius red.
Results
HSCs exposed to TJ135 dose-dependently maintained
quiescent phenotype in culture. TJ135 dose-dependently
inhibited serum-stimulated DNA synthesis of HSCs with-
out affecting the expressions of smooth muscle alpha-
actin and PDGFR beta. In addition, TJ135 dose-depend-
ently inhibited DNA synthesis of HSCs under PDGF stim-
ulation (20 ng/ml). Analysis of the signal transduction
under PDGF stimulation indicated that TJ135 inhibited
expressions of phospho-tyrosine at 170 kDa, phospho-
Raf, phospho-MAPK and phospho-Akt without affecting
their total protein level.
HSCs exposed to Rhubarb Rhizome, a TJ135 component,
dose-dependently maintained quiescent morphology
with dendritic processes. Rhubarb Rhizome dose-depend-
ently inhibited DNA synthesis of HSCs, but had negligible
effect on the expressions of smooth muscle alpha-actin
and PDGFR beta. Further analysis revealed that emodin, a
component of Rhubarb Rhizome, dose-dependently inhib-
ited DNA synthesis of HSCs.
In vivo, TJ135 administration suppressed the development
of liver fibrosis.
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Discussion
In the present study, TJ 135 was found to suppress the pro-
liferation of HSC [7] by hampering the action of PDGF-
BB. Emodin contained in Rhubarb Rhizome may be a major
player inhibiting HSC proliferation and morphological
transformation into myofibroblasts. In vivo, TJ135 was
found to suppress the development of liver fibrosis. Thus,
TJ135 might have a clinical potential suppressing liver
fibrogenesis.
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